Company Info
| Phone: | (844) 445-8843 |
| Year Established: | 2003 |
| Ticker: | ALIM |
| Exchange: | NASDAQ |
Contacts
| Primary: | Rick Eiswirth President & CEO |
| Other: | Philip Ashman President, International Operations Todd Wood President, US Operations |
Company Description
Alimera Sciences is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmology treatments for the management of retinal diseases.
